Geode Capital Management
EW icon

Geode Capital Management’s Edwards Lifesciences EW Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$990M Buy
12,722,416
+45,555
+0.4% +$3.55M 0.07% 252
2025
Q1
$915M Sell
12,676,861
-970,480
-7% -$70.1M 0.07% 248
2024
Q4
$1.01B Buy
13,647,341
+126,194
+0.9% +$9.32M 0.08% 219
2024
Q3
$889M Buy
13,521,147
+284,918
+2% +$18.7M 0.07% 249
2024
Q2
$1.22B Buy
13,236,229
+141,603
+1% +$13M 0.11% 162
2024
Q1
$1.25B Buy
13,094,626
+226,482
+2% +$21.6M 0.12% 157
2023
Q4
$978M Buy
12,868,144
+176,345
+1% +$13.4M 0.1% 179
2023
Q3
$877M Buy
12,691,799
+279,749
+2% +$19.3M 0.1% 176
2023
Q2
$1.17B Buy
12,412,050
+197,431
+2% +$18.6M 0.14% 126
2023
Q1
$1.01B Buy
12,214,619
+78,376
+0.6% +$6.47M 0.13% 135
2022
Q4
$904M Buy
12,136,243
+205,714
+2% +$15.3M 0.13% 155
2022
Q3
$985M Buy
11,930,529
+199,365
+2% +$16.5M 0.15% 123
2022
Q2
$1.11B Buy
11,731,164
+272,554
+2% +$25.9M 0.16% 111
2022
Q1
$1.35B Buy
11,458,610
+358,768
+3% +$42.1M 0.17% 104
2021
Q4
$1.43B Buy
11,099,842
+517,261
+5% +$66.8M 0.17% 101
2021
Q3
$1.19B Buy
10,582,581
+358,020
+4% +$40.4M 0.16% 112
2021
Q2
$1.06B Buy
10,224,561
+312,507
+3% +$32.3M 0.15% 121
2021
Q1
$827M Buy
9,912,054
+122,660
+1% +$10.2M 0.13% 138
2020
Q4
$891M Sell
9,789,394
-238,879
-2% -$21.7M 0.15% 124
2020
Q3
$799M Sell
10,028,273
-124,541
-1% -$9.92M 0.16% 119
2020
Q2
$700M Buy
10,152,814
+6,723,733
+196% +$464M 0.15% 133
2020
Q1
$646M Sell
3,429,081
-83,068
-2% -$15.6M 0.17% 123
2019
Q4
$818M Buy
3,512,149
+210,206
+6% +$49M 0.17% 113
2019
Q3
$725M Buy
3,301,943
+563,677
+21% +$124M 0.17% 113
2019
Q2
$505M Sell
2,738,266
-197,498
-7% -$36.4M 0.12% 165
2019
Q1
$561M Sell
2,935,764
-6,730
-0.2% -$1.29M 0.15% 130
2018
Q4
$450M Buy
2,942,494
+202,248
+7% +$30.9M 0.14% 143
2018
Q3
$476M Buy
2,740,246
+78,928
+3% +$13.7M 0.13% 144
2018
Q2
$387M Buy
2,661,318
+106,940
+4% +$15.5M 0.12% 166
2018
Q1
$356M Buy
2,554,378
+152,169
+6% +$21.2M 0.12% 179
2017
Q4
$270M Buy
2,402,209
+93,049
+4% +$10.5M 0.09% 223
2017
Q3
$252M Buy
2,309,160
+61,244
+3% +$6.68M 0.09% 218
2017
Q2
$265M Sell
2,247,916
-29,750
-1% -$3.51M 0.1% 196
2017
Q1
$214M Buy
2,277,666
+128,920
+6% +$12.1M 0.09% 237
2016
Q4
$201M Buy
2,148,746
+92,820
+5% +$8.69M 0.09% 218
2016
Q3
$248M Buy
2,055,926
+104,160
+5% +$12.5M 0.12% 166
2016
Q2
$194M Buy
1,951,766
+64,458
+3% +$6.42M 0.11% 199
2016
Q1
$166K Buy
1,887,308
+66,142
+4% +$5.82K 0.09% 225
2015
Q4
$144M Buy
1,821,166
+928,337
+104% +$73.2M 0.08% 250
2015
Q3
$127M Sell
892,829
-53,796
-6% -$7.63M 0.08% 267
2015
Q2
$135M Buy
946,625
+6,784
+0.7% +$965K 0.08% 263
2015
Q1
$134M Buy
939,841
+56,547
+6% +$8.04M 0.08% 272
2014
Q4
$112M Buy
883,294
+35,386
+4% +$4.5M 0.07% 303
2014
Q3
$86.5M Sell
847,908
-1,443
-0.2% -$147K 0.06% 338
2014
Q2
$72.9M Buy
849,351
+73,576
+9% +$6.31M 0.05% 385
2014
Q1
$57.5M Sell
775,775
-9,625
-1% -$714K 0.04% 430
2013
Q4
$51.6M Sell
785,400
-11,700
-1% -$769K 0.04% 448
2013
Q3
$55.5M Buy
797,100
+21,425
+3% +$1.49M 0.04% 400
2013
Q2
$52.1M Buy
+775,675
New +$52.1M 0.05% 387